Device Trial Radar · NCT06546306
Post Market Clinical Follow-Up TOUCH® CMC 1
Last checked: Nov 20, 2026Latest source record: Sep 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
216
Actual
Start
Nov 22, 2019
Primary completion
Feb 22, 2022
Study completion Dec 2031
Sponsor
- Lead sponsor
- Keri Medical SANot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 9, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Because severe pain, weakened pinch and grip strength produce functional disabilities, the basal joint of the thumb is the most common site of surgical reconstruction in the upper limb due to OA. The cement-free dual mobility Touch® prosthesis consists of a metacarpal implant (stem), a trapezium implant (cup), and a connection implant (neck). The main objective of this study is to describe the performance and safety of the Touch® prosthesis used with its instruments set in accordance with its intention and CE marking in force. Performance and safety will be assessed over the short and long term in accordance with the life cycle of the Touch® prosthesis.
Conditions
- Osteoarthritis Thumb
Interventions
TOUCH® CMC 1Device
TOUCH® prosthesis is a total CMC 1 (1st Carpo-metacarpal) joint replacement prosthesis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mobility and painTime frame: 3 months
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
Centre de la main du Pays d'Aix
Aix-en-Provence, France
Clinic of Chataigneraie
Beaumont, France
Orthopaedics and Trauma Surgery Practice
Bezannes, France
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.